The European League Against Rheumatism (EULAR) - 16th Annual European Congress (June 10-13, 2015 - Rome, Italy).
The 16th Annual European Congress of Rheumatology, organized by the European League Against Rheumatism (EULAR), provided the latest advances in the field of rheumatologic diseases to around 14,000 participants from more than 120 countries. This congress has become the primary platform for exchange of scientific and clinical information and the biggest rheumatology event in Europe. The congress covered a broad spectrum of the rheumatic diseases through 400 lectures, workshops, 300 oral presentations, 2,000 posters, 350 invited speakers, and basic science and clinical symposia.
Thomson Reuters, Barcelona, Spain. scientific.prousjournals@thomsonreuters.com.
M
M
Ollé
D000818:Animals; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D002986:Clinical Trials as Topic; D055808:Drug Discovery; D006801:Humans; D007558:Italy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D012219:Rheumatology; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D018501:Antirheumatic Agents
Blisibimod; CR-6086; Fosdagrocorat; INV-17; Namilumab; Nintedanib; SB-4; Tocilizumab; XmAb-5871